美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

大麻股

233.05

+0.17900.08%

漲家數：6

跌家數：9

平家數：2

市盈率：- -

高：233.73

開：232.81

低：230.85

收：232.87

成交量：1,500.37萬

成交額：5,963.57萬

市值：558.31億

流通市值：506.62億

資料載入中...

總覽新聞資訊

AIM ImmunoTech Inc. 將本票到期日延長至2027年6月30日；未償餘額為168萬美元

AIM ImmunoTech宣佈股東權益顯著增長及本票到期日延至2027年6月，提升財務靈活性並支持戰略臨床重點

梯瓦研究揭示：僅23%患有情緒障礙與遲發性運動障礙症狀的年輕成人獲正式TD診斷，儘管影響廣泛

中國抗體-B(03681)於2026年SID年會上公布抗CGC抗體(hC2)臨床前研究

Catcher Predict：「Counter-Strike: TheMongolz 對 Aurora Gaming (BO3) - PGL Astana 小組賽」「奇數/偶數總擊殺」勝率飆升 40%

Veru發布2026財年第二季度財報及2B期高原臨床試驗進展

沽空巨頭香櫞創始人受審：Cronos Group CEO 出庭對質，揭秘「沽空抹黑」涉案細節

Catcher Predict：「Counter-Strike：MOUZ 對 Aurora Gaming（BO3）- PGL Astana 小組賽」「奇數/偶數總擊殺數」勝率飆升 40%

AIM ImmunoTech公布UPMC複發性卵巢癌二期臨床試驗達到50%客觀緩解率，顯示突破性聯合療法潛力

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4557/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4557","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"大麻股","latestPrice":233.04813,"timestamp":1779204765420,"preClose":232.86917,"halted":0,"volume":15003431,"delay":0,"changeRate":0.000768,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":0.178955,"latestTime":"05-19 11:32:46 EDT","open":232.8062,"high":233.73172,"low":230.84805,"amount":59635741.663033,"amplitude":0.012383,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1779220800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.165745,"peRate":229.799635,"turnoverRate":0.005073,"increases":6,"decrements":9,"flats":1,"marketCap":55830752281.75,"floatMarketCap":50661841431},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","high":233.73172,"amplitude":0.012383,"preClose":232.86917,"low":230.84805,"pbRate":"3.165745","latestPrice":233.04813,"volume":15003723,"delay":0,"open":232.8062,"prevYearClose":226.48174,"prevWeekClose":234.4467,"prevMonthClose":241.3523,"prevQuarterClose":214.6689,"fiveDayClose":238.9178,"twentyDayClose":219.4974,"sixtyDayClose":241.4301,"secType":"PLATE","market":"US","turnoverRate":0.005073,"peRate":229.799635,"marketCap":55830752281.75,"floatMarketCap":50661841431,"timestamp":1779204770278,"nameCN":"大麻股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4557\",,,,undefined,":{"bkCode":"BK4557","up":6,"down":9,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4557\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1130658270","title":"AIM ImmunoTech Inc. 將本票到期日延長至2027年6月30日；未償餘額為168萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130658270","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130658270?lang=zh_tw&edition=fundamental","pubTime":"2026-05-19 20:07","pubTimestamp":1779192448,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech Inc. 宣布，已将其一项本票的到期期限延长。新的到期日设定为2027年6月30日。根据公司披露的信息，该票据当前的未偿还本金余额为168万美元。此举为公司管理其债务结构提供了更长的缓冲时间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIM","BK4139","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136334748","title":"AIM ImmunoTech宣佈股東權益顯著增長及本票到期日延至2027年6月，提升財務靈活性並支持戰略臨床重點","url":"https://stock-news.laohu8.com/highlight/detail?id=1136334748","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136334748?lang=zh_tw&edition=fundamental","pubTime":"2026-05-19 20:02","pubTimestamp":1779192142,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech Inc. 近日宣布了两项关键的财务进展，旨在强化其资产负债表并为未来的战略推进提供动力。公司股东权益实现了显著提升，同时，一项重要的本票到期日已成功延长至2027年6月。这些举措共同增强了公司的财务灵活性，使其能够更专注于推进核心的临床研发优先事项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4139","AIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118285288","title":"梯瓦研究揭示：僅23%患有情緒障礙與遲發性運動障礙症狀的年輕成人獲正式TD診斷，儘管影響廣泛","url":"https://stock-news.laohu8.com/highlight/detail?id=1118285288","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118285288?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 20:01","pubTimestamp":1779105679,"startTime":"0","endTime":"0","summary":"一项由梯瓦制药进行的研究发现，在患有情绪障碍并表现出迟发性运动障碍症状的年轻成人群体中，仅有23%的人获得了正式的TD诊断。这一数据凸显出，尽管该疾病的影响广泛存在，但在临床实践中仍存在显著的诊断不足问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4007","BK4585","BK4557","LU1983299246.USD","BK4566","TEVA","BK4559","BK4596","BK4584","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635593711","title":"中國抗體-B(03681)於2026年SID年會上公布抗CGC抗體(hC2)臨床前研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2635593711","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635593711?lang=zh_tw&edition=fundamental","pubTime":"2026-05-14 19:16","pubTimestamp":1778757360,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国抗体-B 发布公告，本公司自主研发的全球首创人源化抗gc抗体–新型抗CGC抗体 hC2，在用于治疗斑秃及白癜风的人源化动物模型中的临床前研究结果已于2026年5月14日在美国芝加哥举行的2026年皮肤病学研究学会年会上公布。在斑秃模型中，hC2给药显著减少脱发;在白癜风模型中，显著减轻皮肤脱色。我们目前正在针对该抗体进行CMC优化及毒理学研究，并计划最早在2026年第四季度提交我们治疗斑秃的IND申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SID","BK1574","BK4007","03681","CGC","BK4557","BK4006","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635588735","title":"Catcher Predict：「Counter-Strike: TheMongolz 對 Aurora Gaming (BO3) - PGL Astana 小組賽」 「奇數/偶數總擊殺」 勝率飆升 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635588735","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635588735?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 22:30","pubTimestamp":1778682608,"startTime":"0","endTime":"0","summary":" 据 Catcher Predict 监测，预测市场 Polymarket 上 “Counter-Strike: TheMongolz 对 Aurora Gaming (BO3) - PGL Astana 小组赛” 事件中，子市场 “奇数/偶数总击杀” 的 “奇数” 选项胜率发生剧烈波动，由 1 小时前的 50% 飙升至当前的 90%（波动幅度达 40%）。请注意相关突发消息影响。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2264548","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MSOS","ACB","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176456050","title":"Veru發布2026財年第二季度財報及2B期高原臨床試驗進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1176456050","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176456050?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 18:33","pubTimestamp":1778668401,"startTime":"0","endTime":"0","summary":"Veru Inc.近日公布了其2026财年第二季度的财务业绩，并同步更新了其处于2B期阶段的高原临床试验的最新进展。公司本季度的财务表现与关键临床项目的推进情况，共同勾勒出其当前的发展图景与未来的战略重心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERU","BK4007","BK4557","BK4183","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635273019","title":"沽空巨頭香櫞創始人受審：Cronos Group CEO 出庭對質，揭秘「沽空抹黑」涉案細節","url":"https://stock-news.laohu8.com/highlight/detail?id=2635273019","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635273019?lang=zh_tw&edition=fundamental","pubTime":"2026-05-13 11:46","pubTimestamp":1778643978,"startTime":"0","endTime":"0","summary":"戈伦斯坦周二作为第一位证人出庭，指证美国政府起诉莱夫特的案件。戈伦斯坦表示，莱夫特歪曲了 Cronos 在2018年向投资者发表的声明。彼时的Cronos Group可谓是资本市场的宠儿。香橼在报告中指出，Cronos 故意误导投资者，夸大了其销售渠道的稳固程度。报告发布时，Cronos 的股价正处于历史高位，市值与其微薄的营收完全脱节。在报告发布当天，Cronos 股价应声暴跌 28%，市值瞬间缩水。做空闹剧落幕香橼对 Cronos 的做空是一场典型的“心理战”与“数据战”的结合。","market":"sh","thumbnail":"https://community-static.tradeup.com/news/c69ca04ca98a27416d65d74bb16a1dbe","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/c69ca04ca98a27416d65d74bb16a1dbe"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441046.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CRON","BK4007","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634529158","title":"Catcher Predict：「Counter-Strike：MOUZ 對 Aurora Gaming（BO3）- PGL Astana 小組賽」 「奇數/偶數總擊殺數」 勝率飆升 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634529158","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634529158?lang=zh_tw&edition=fundamental","pubTime":"2026-05-12 16:45","pubTimestamp":1778575510,"startTime":"0","endTime":"0","summary":" 据 Catcher Predict 监测，预测市场 Polymarket 上“Counter-Strike：MOUZ 对 Aurora Gaming（BO3）- PGL Astana 小组赛”事件中，子市场“奇数/偶数总击杀数”的“奇数”选项胜率发生剧烈波动，由 1 小时前的 50% 飙升至当前的 90%（波动幅度达 40%）。请注意相关突发消息影响。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2264172","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","ACB","MSOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108100839","title":"AIM ImmunoTech公布UPMC複發性卵巢癌二期臨床試驗達到50%客觀緩解率，顯示突破性聯合療法潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1108100839","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108100839?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 20:24","pubTimestamp":1778156658,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech Inc. 近日宣布，其在UPMC开展的针对复发性卵巢癌的二期临床试验取得了令人瞩目的中期结果。数据显示，该试验达到了50%的客观缓解率（ORR），这一积极信号强烈暗示了其研究药物在联合疗法中可能具备突破性的治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIM","BK4139","BK4557"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}